WHO ICTRP trial
Multicenter, Double-Blind, Randomized, Controlled, Parallel Comparison of…
EUCTR2006-006449-14-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-006449-14-DE |
|---|---|
| Public title | Multicenter, Double-Blind, Randomized, Controlled, Parallel Comparison of Efficacy and Safety of Fixed Doses of Two Formulations of Botulinum Toxin Type A in the Treatment of Moderate to Severe Cervical Dystonia (BOTOX® 200 Units and Dysport® 750 Units) |
| Scientific title | Multicenter, Double-Blind, Randomized, Controlled, Parallel Comparison of Efficacy and Safety of Fixed Doses of Two Formulations of Botulinum Toxin Type A in the Treatment of Moderate to Severe Cervical Dystonia (BOTOX® 200 Units and Dysport® 750 Units) |
| Primary sponsor | Allergan Inc. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany;Italy |
| Conditions | Moderate to Severe Cervical Dystonia |
| Interventions | Trade Name: BOTOX® Pharmaceutical Form: Powder for injection* Trade Name: Dysport® Pharmaceutical Form: Powder for injection* |
| Registration date | Aug 14, 2007 |
| Target size | 160 |
| Secondary IDs | MedAff-BTX-0616 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: